RecruitingPhase 3NCT06959095
Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation
Sponsor: GlaxoSmithKline
Bakersfield, CA · Modesto, CA · Newport Beach, CA · +39 more sites